Melodiol Global Health Limited (ASX:ME1) (‘Melodiol’ or ‘the Company’) is pleased to provide the following corporate updates. La Plata Facility Further to ME1’s announcement on 4 September 2023, the Company provides the following update with respect to La Plata Capital, LLC’s (“La Plata”) secured note holding in the Company. Per the terms of the previous […]
Emyria Limited (ASX: EMD) (“Emyria”, or the “Company”) focused on developing innovative treatments for mental health and neurological conditions, is pleased to announce the appointment of Greg Hutchinson as Independent Non-Executive Chairman. HIGHLIGHTS Strategic Appointment: Emyria welcomes Mr. Greg Hutchinson as Independent Non-Executive Chairman to bolster the Company’s innovative mental health research and development programs […]
Tap into the green gold rush! The Investing News Network (INN) spoke with analysts, market watchers and insiders about which trends willimpact the cannabis sector. ✓ Trends ✓ Forecasts ✓ Top Stocks Table of Contents: Cannabis Market Update: Q1 2023 in Review Cannabis Market Update: Q2 2023 in Review Cannabis Market Update: Q3 2023 in […]
With over 1.3 million Canadians currently struggling with trauma and post-traumatic stress disorder (PTSD), Pure Life Healthcare Management is working to offer a wrap-around care model for better healing, according to CEO Doug Page. The model allows individuals to walk in and have a single health provider deliver a wide spectrum of support for healing. […]
Emyria Limited (ASX: EMD) (“Emyria”, or the “Company”) focused on developing innovative treatments for mental health and neurological conditions, is pleased to announce the appointment of Greg Hutchinson as Independent Non-Executive Chairman. HIGHLIGHTS Strategic Appointment: Emyria welcomes Mr. Greg Hutchinson as Independent Non-Executive Chairman to bolster the Company’s innovative mental health research and development programs […]
Melodiol Global Health Limited (ASX:ME1) (‘Melodiol’ or ‘the Company’) provides an update to its previously announced capital raise and debt conversions (refer to ASX announcement dated 26 October 2023). In an effort to accelerate the receipt of funds, the Company has re-priced the issue price per fully paid ordinary share (‘Shares’) for the capital raise […]
About 70% of Americans think marijuana use should be legal, after holding steady at 68% for three years, according to Gallup polling data released Wednesday. Since crossing the 30% mark in 2000, support for legal cannabis accelerated after 2010 to more than half of Americans in 2013. In the latest figures, 29% of Americans think […]
Description The securities of Melodiol Global Health Limited (‘ME1’) will be placed in trading halt at the request of ME1, pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Monday, 13 November 2023 or when the announcement is […]
Melodiol Global Health Limited (ASX:ME1) (‘Melodiol’ or ‘the Company’) is pleased to provide the following update on progress for the three month period ended 30 September 2023 (the ‘quarter’), as well as its Appendix 4C. All financial results are in Australian dollars and unaudited (unless otherwise stated). Highlights: ~$7.5m in unaudited revenue achieved across the […]
Melodiol Global Health Limited (ASX:ME1) (‘Melodiol’ or ‘the Company’) is pleased to provide the following update on progress for the three month period ended 30 September 2023 (the ‘quarter’), as well as its Appendix 4C. All financial results are in Australian dollars and unaudited (unless otherwise stated). Highlights: ~$7.5m in unaudited revenue achieved across the […]